SF
NEO icon

Synovus Financial’s NeoGenomics NEO Stock Holding History

Synovus Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,246
Closed -$243K – 878
2021
Q3 		$243K Sell
5,246
-7,831
-60% -$363K ﹤0.01% 777
2021
Q2 		$592K Sell
13,077
-622
-5% -$27.6K 0.01% 568
2021
Q1 		$654K Sell
13,699
-259
-2% -$13.5K 0.01% 496
2020
Q4 		$757K Sell
13,958
-2,328
-14% -$105K 0.01% 443
2020
Q3 		$600K Buy
16,286
+463
+3% +$17.2K 0.01% 449
2020
Q2 		$490K Buy
15,823
+3,940
+33% +$109K 0.01% 465
2020
Q1 		$328K Sell
11,883
-2,183
-16% -$65.4K ﹤0.01% 648
2019
Q4 		$410K Sell
14,066
-6,430
-31% -$153K 0.01% 519
2019
Q3 		$393K Buy
+20,496
New +$481K 0.01% 515

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Synovus Financial's NEO Position: Q4 2021 in Review

Synovus Financial sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 5,246 shares — an estimated $243K sold.

Synovus Financial first reported a position in NEO in Q3 2019 and held it in 9 quarters. The position peaked at $757K in Q4 2020. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Synovus Financial reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Synovus Financial sold 5,246 NeoGenomics shares in Q4 2021, an estimated $243K.
  • Synovus Financial first reported a position in NeoGenomics in Q3 2019 and held it in 9 quarters.
  • Synovus Financial's NeoGenomics position peaked at $757K in Q4 2020.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Synovus Financial's 13F filing for Q4 2021, filed 14 Feb 2022.